| Joaquin Duato |
Joaquin Duato currently works at Johnson & Johnson, as Chairman & Chief Executive Officer from 2023. Mr. Duato also formerly worked at Pharmaceutical Research & Manufacturers of America, as Chairman from 2017 to 2018, Hess Corp., as Independent Director from 2019 to 2022, United States Fund for UNICEF, as Director from 2019 to 2021, CEO Roundtable on Cancer, Inc., as Director, Janssen Cilag SpA, as Managing Director, U.S.-Spain Council, Inc., as Director, Ortho Biotech Products LP, as President, and Save The Children Federation Inc., as Trustee. Mr. Duato received his graduate degree from Thunderbird School of Global Management and Masters Business Admin degree from Escuela Superior de Administración y Dirección de Empresas. |
| Kristen Blair Mulholland |
Kristen Blair Mulholland currently works at Johnson & Johnson, as Chief Human Resources Officer & Executive VP from 2024. Ms. Mulholland received her graduate degree from Case Western Reserve University and undergraduate degree from Tulane University (Louisiana). |
| Kathryn E. Wengel |
Kathryn E. Wengel currently works at National Association of Manufacturers, as Chairman, Laboratory Corp. of America Holdings, as Independent Director from 2021, GS1 AISBL, as Director, Labcorp Holdings, Inc., as Independent Director from 2024, Johnson & Johnson, as Chief Technical Operations & Risk Officer from 2023, and Associazione Nazionale Produttori Illuminazione, as Member. Ms. Wengel received her undergraduate degree from Princeton University. |
| James D. Swanson |
James D. Swanson currently works at Johnson & Johnson, as Chief Information Officer & Executive VP from 2022. Mr. Swanson also formerly worked at Monsanto Co., as Director & Chief Information Officer in 2018, Merck & Co., Inc., as Vice President-Information Technology from 2005 to 2013, Bayer CropScience, Inc., as Chief Information Officer from 2018 to 2019, and Johnson & Johnson Pharmaceutical Group, as Chief Information Officer & Vice President. Mr. Swanson received his undergraduate degree and graduate degree from Drexel University. |
| Joseph J. Wolk |
Joseph J. Wolk currently works at Johnson & Johnson, as Chief Financial Officer & Executive Vice President from 2018, St. Joseph's University, as Trustee, Stanford University School of Medicine, as Member, Cnbc Global Cfo Council, as Member, and Wall Street Journal Cfo Network, as Member. Mr. Wolk also formerly worked at Kenvue, Inc., as Director from 2023 to 2024 and Janssen Pharmaceuticals, Inc., as Chief Financial Officer & Vice President-Finance from 2014 to 2016. Mr. Wolk received his undergraduate degree from St. Joseph's University and graduate degree from Temple University Beasley School of Law. |
| Robert J. Decker |
Mr. Robert J. Decker is a Chief Accounting Officer & Controller at Johnson & Johnson. He received his undergraduate degree from Rider University. |
| Elizabeth Forminard |
Elizabeth Forminard currently works at Johnson & Johnson, as Chief Legal Officer & Executive Vice President. Ms. Forminard received her undergraduate degree from Cornell University and graduate degree from The University of Pennsylvania Law School. |
| Penny M. Heaton |
Penny M. Heaton currently works at Johnson & Johnson, as Chief Medical Officer from 2024 and Pediatric Infectious Diseases Society, as Member. Dr. Heaton also formerly worked at Merck & Co., Inc., as Director-Vaccines Clinical Research from 1999 to 2006, Novavax, Inc., as Chief Medical Officer from 2006 to 2009, and Centers for Disease Control & Prevention, as Medical Officer. Dr. Heaton received her undergraduate degree from the University of Louisville. |
| Marillyn A. Hewson |
Marillyn A. Hewson currently works at The Business Roundtable, as Vice Chairman, The Kennedy Center Corporate Fund, as Vice Chairman, Chevron Corp., as Independent Director from 2021, and various other companies. Ms. Hewson also formerly worked at Lockheed Martin Ventures, as Chairman, President & CEO from 2014 to 2020, Lockheed Martin Corp., as Executive Chairman from 2020 to 2021, Lockheed Martin Investment Management Co., as Executive Chairman from 2020 to 2022, and various other companies. Ms. Hewson received her undergraduate degree in 1976 from The University of Alabama and graduate degree in 1979 from The University of Alabama. |
| Darius Adamczyk |
Darius Adamczyk currently works at Honeywell International, Inc. (Minnesota), as Chief Executive Officer, Quantinuum Ltd., as Chairman from 2018, Johnson & Johnson, as Independent Director from 2022, Council on Foreign Relations, Inc., as Member, The Business Roundtable, as Member, The Business Council, as Member, US-China Business Council, as Member, and Aspen Economic Strategy Group, as Member. Mr. Adamczyk also formerly worked at Metrologic Instruments, Inc., as Chief Executive Officer & Director from 2007 to 2008, Honeywell Process Solutions, as President & Chief Executive Officer from 2012 to 2014, Honeywell International, Inc., as Executive Chairman from 2023 to 2024, Garrett Motion, Inc., as Director in 2021, GE Aerospace, as Electrical Engineer, Booz Allen Hamilton, Inc., as Senior Associate, and Honeywell Scanning & Mobility, as President from 2008 to 2012. Mr. Adamczyk received his undergraduate degree in 1988 from Michigan State University, Masters Business Admin degree in 1995 from Harvard University, and graduate degree in 1991 from Syracuse University. |
| Jennifer A. Doudna |
Jennifer A. Doudna is the founder of Caribou Biosciences, Inc. (2011), Editas Medicine, Inc. (2013), Intellia Therapeutics, Inc. (2014), and Innovative Genomics Institute (2014) where the title held is Chairman & President. Dr. Doudna is also the founder of Mammoth Biosciences, Inc., Scribe Therapeutics, Inc. Current jobs include Independent Director at Johnson & Johnson (2018), Director at Driver, Inc., Director at Altos Labs, Inc., Independent Director at Tempus AI, Inc. (2021), Trustee at Pomona College, Professor at the University of California, Berkeley (2002), Member-Molecular, Cell Biology & Chemistry at Lawrence Berkeley National Laboratory, Member-Molecular, Cell Biology & Chemistry at National Academy of Sciences, Member-Molecular, Cell Biology & Chemistry at American Academy of Arts & Sciences, Chancellor Chair at Li Ka Shing (Canada) Foundation, iPartner at The Column Group LLC, Chief Science Advisor at TPG Sixth Street Partners LLC (2022), and Scientific Advisory Board at eFFECTOR Therapeutics, Inc. Former jobs include Vice President-Discovery Research at Genentech, Inc., Consultant at Pfizer Inc., Member at The Royal Society, Member-Molecular, Cell Biology & Chemistry at Howard Hughes Medical Institute, Inc., Advisor at Orchard Venture Partners, and Consultant at Merck Ltd. Education includes a doctorate from Harvard University and an undergraduate degree from Pomona College. |
| Anne M. Mulcahy |
Anne M. Mulcahy currently works at Graham Holdings Co., as Chairman, The Business Roundtable, as Chairman-Corporate Governance Task Force, Johnson & Johnson, as Independent Director from 2024, LPL Financial Holdings, Inc., as Independent Director from 2013, Catalyst, Inc., as Director, The John F. Kennedy Center for the Performing Arts, as Director, LPL Holdings, Inc., as Director, and WP Co. LLC, as Director. Ms. Mulcahy also formerly worked at Xerox Corp., as Chairman from 2009 to 2010, Save The Children Federation Inc., as Chairman from 2010 to 2017, Federal National Mortgage Association, as Director in 2004, Citigroup, Inc., as Director in 2010, Target Corp., as Independent Director from 1997 to 2017, FUJIFILM Business Innovation Corp., as Director, Washington Post Co., as Director, Williams-Sonoma, Inc., as Independent Director from 2018 to 2022, and Save The Children Federation Inc., as Trustee. Ms. Mulcahy received her undergraduate degree from Marymount College. |
| Eugene A. Woods |
Eugene A. Woods currently works at The Charlotte-Mecklenburg Hospital Authority (North Carolina), as President & Chief Executive Officer from 2016, Carolinas College of Health Sciences, as President & Chief Executive Officer from 2016, Atrium Health, Inc., as President & Chief Executive Officer from 2016, Advocate Health, Inc., as Co-Chief Executive Officer from 2022, Advocate Aurora Health, Inc., as Chief Executive Officer, Johnson & Johnson, as Independent Director from 2023, North Carolina Baptist Hospital, as Director, Scottsdale Institute, as Director, and Wake Forest Baptist Medical Center, as Director. Mr. Woods also formerly worked at St. Joseph Health System, as Chief Executive Officer & SVP-Operations from 2005 to 2011, Roy Lester Schneider Hospital, as President & Chief Executive Officer from 1998 to 2001, American Hospital Association, Inc., as Chairman from 2012 to 2017, Federal Reserve Bank of Richmond, as Chairman, Best Buy Co., Inc., as Independent Director from 2018 to 2024, Bon Secours Mercy Health Petersburg LLC, as Vice President-Administration from 1993 to 1998, CHRISTUS Health, Inc., as President & Chief Operating Officer from 2014 to 2016, and Washington Hospital Center Corp., as Chief Operating Officer & Senior Vice President from 2001 to 2005. Mr. Woods received his undergraduate degree, graduate degree, and Masters Business Admin degree from The Pennsylvania State University. |
| Mark Alan Weinberger |
Mark Alan Weinberger was the founder of Washington Counsel PC, serving as Principal from 1996 to 2000. Current jobs include Independent Director at Johnson & Johnson since 2019, Independent Director at MetLife, Inc. since 2019, Independent Director at JPMorgan Chase & Co. starting in 2024, Director at National Bureau of Economic Research, Inc., Director at The Tax Council, Director at The Bullis School, Inc., Director at Ernst & Young (Nigeria) since 2019, Director at MetLife Services & Solutions LLC, Independent Non-Executive Director at Saudi Arabian Oil Co. since 2019, Director at JUST Capital Foundation, Inc., Trustee at Emory University, Trustee at Case Western Reserve University, Trustee at United States Council for International Business, Trustee at The Concord Coalition, Trustee at The American Council for Capital Formation, Member at Aspen Economic Strategy Group, and Trustee at Greater Washington Partnership. Former jobs include Chairman & Chief Executive Officer at Ernst & Young LLP from 2013 to 2019, Vice Chairman at The Kennedy Center Corporate Fund, Director at Catalyst, Inc. from 2013 to 2019, Director at The Business Roundtable from 2014 to 2019, Independent Director at Accelerate Acquisition Corp. from 2021 to 2022, Assistant Secretary at U.S. Department of the Treasury from 2001 to 2002, Member of the International Business Council at Forum Mondial de L'Economie, Member at The International Business Council, Chief Tax & Budget Counsel at United States Senate, Partner at Oldaker Law Group LLP from 1995 to 1996, and Partner at Ryan Phillips Utrecht & Mackinnon from 1995 to 1996. Education includes an undergraduate degree from Emory University in 1983, a graduate degree from Case Western Reserve University in 1987, an MBA from Case Western Reserve University in 1986, and a graduate degree from Georgetown University Law Center in 1991. |
| Mary C. Beckerle |
Mary C. Beckerle currently works at the University of Utah Health Care, as Chief Executive Officer-Huntsman Cancer Institute from 2006, Huntsman Cancer Institute, as Chief Executive Officer from 2006, Johnson & Johnson, as Independent Director from 2015, Huntsman International LLC, as Director, Exelixis, Inc., as Independent Director from 2024, Huntsman Corp., as Independent Director from 2011, Coalition For Life Sciences, as Director, the University of Pennsylvania, as Member-Cancer Policy, the University of Utah, as Professor from 2013, National Academy of Sciences, as Member, American Philosophical Society, as Member, Duke University School of Medicine, as Member-Cancer Policy, Georgetown University Medical Center, as Member-Cancer Policy, National Center For Biological Sciences, as Member-Cancer Policy, and American Academy of Arts & Sciences, as Member. Dr. Beckerle also formerly worked at National Cancer Institute, as Chief Executive Officer, American Cancer Society, Inc., as Chairman-Council for Extramural Grants, Howard Hughes Medical Institute, Inc., as Director, National Institutes of Health, as Director, Huntsman Cancer Foundation, as Director from 2015 to 2017, American Association for Cancer Research, as Director, and The American Society for Cell Biology, as President. Dr. Beckerle received her doctorate degree from The University of Colorado and undergraduate degree from Wells College. |
| Hubert Joly |
Hubert Joly currently works at Minnesota Business Partnership, Inc., as Vice Chairman, The Business Council, as Vice Chairman, Johnson & Johnson, as Independent Director from 2019, Ralph Lauren Corp., as Lead Independent Director from 2021, Sciences Po American Foundation, as Director, The New York Public Library Astor Lenox & Tilden Foundations, as Trustee, Minnesota Orchestral Association, as Trustee, and The Minneapolis Society of Fine Arts, as Trustee. Mr. Joly also formerly worked at Vivendi SE, as Chief Executive Officer-Video Game Unit, Carlson, Inc., as President, Chief Executive Officer & Director from 2008 to 2012, CWT US LLC, as Chairman, President & Chief Executive Officer from 2004 to 2008, Radisson Hospitality LLC, as President & Chief Executive Officer, Park Inn Hotels, as President, Chief Executive Officer & Director, CW Travel Holdings NV, as President, Chief Executive Officer & Director, Best Buy Co., Inc., as Executive Chairman from 2019 to 2020, Radisson Hospitality AB, as Vice Chairman in 2012, Retail Industry Leaders Association, as Vice Chairman, World Travel & Tourism Council Ltd., as Director, Electronic Data Systems Corp., as Vice President-European Region, McKinsey & Co., Inc., as Partner, Vivendi Universal Games, Inc., as Executive VP-American Assets & Deputy CFO from 2002 to 2004, and Electronic Data Systems France SAS, as President & Vice President-Europe from 1996 to 1999. Mr. Joly received his undergraduate degree from Sciences Po and undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Nadja Y. West |
Dr. Nadja Y. West, MD, is an Independent Director at Tempus AI, Inc., an Independent Director at Johnson & Johnson, an Independent Director at Tenet Healthcare Corp. and an Independent Director at Nucor Corp. He is on the Board of Directors at Tempus AI, Inc., Johnson & Johnson, Tenet Healthcare Corp., Nucor Corp., AmeriCares Foundation, Inc., Woodruff Foundation, The National Collegiate Athletic Association, Mount St. Mary's University, Inc. and National Recreation Foundation. Dr. West was previously employed as a Commanding General by U.S. Army Medical Department and a Deputy Chief of Staff by U.S. Army Medical Department. He received his undergraduate degree from US Military Academy, a graduate degree from National Defense University and a doctorate degree from George Washington University School of Medicine & Health. |
| Mark B. McClellan |
Mark B. McClellan currently works at Cigna Holding Co., as Director from 2018, Johnson & Johnson, as Independent Director from 2013, National Council on Aging, Inc., as Director, and various other companies. Dr. McClellan also formerly worked at Aviv REIT, Inc., as Director from 2013 to 2015, USDS, Inc., as Director, The Brookings Institution, as Director-Healthcare Innovation & Value Initiative from 2007 to 2015, and various other companies. Dr. McClellan received his doctorate degree in 1993 from Massachusetts Institute of Technology, undergraduate degree in 1985 from The University of Texas at Austin, doctorate degree in 1989 from Harvard Mit Health Sciences & Technology, and graduate degree in 1991 from Harvard Kennedy School of Government. |
| Paula A. Johnson |
Paula A. Johnson currently works at Johnson & Johnson, as Independent Director from 2023, The Isabella Stewart Gardner Museum, Inc., as Director from 2015, Isabella Stewart Gardner Museum, as Director from 2015, Wellesley College, as President from 2016, The Rockefeller University, as Trustee from 2021, American Academy of Arts & Sciences, as Member, and National Academy of Medicine (United States), as Member. Dr. Johnson also formerly worked at ABIOMED, Inc., as Independent Director from 2021 to 2022, Eaton Vance Corp., as Independent Director from 2018 to 2021, West Pharmaceutical Services, Inc., as Independent Director from 2005 to 2021, The Brigham & Women's Hospital, Inc., as Executive Director-Connors Center from 2002 to 2016, Harvard Medical School, as Associate Professor, and Harvard T.H. Chan School of Public Health, as Professor. Dr. Johnson received her doctorate degree from Harvard Medical School, undergraduate degree from Radcliffe College, and graduate degree from Harvard T.H. Chan School of Public Health. |
